Contact
searchSearch
HMP Global

APP Institute Inflammatory Bowel Disease

Featured

Alexis Oonk
Rapid Refresh
Dive Into Diagnostics
08/15/2024
At the inaugural APP Instititute Inflammatory Bowel Disease, Alexis Oonk, FNP, reviewed how to establish a diagnosis of inflammatory bowel disease, including determining phenotype, assessing the severity of disease, and using biomarkers to...
At the inaugural APP Instititute Inflammatory Bowel Disease, Alexis Oonk, FNP, reviewed how to establish a diagnosis of inflammatory bowel disease, including determining phenotype, assessing the severity of disease, and using biomarkers to...
At the inaugural APP Instititute...
08/15/2024
APP Institute Inflammatory Bowel Disease
Alexis Oonk
Rapid Refresh
Dive Into Diagnosis
08/14/2024
At the inaugural APP Instititute Inflammatory Bowel Disease, FNP, reviews how to establish a diagnosis of inflammatory bowel disease, including determining their phenotype, assessing the severity of their disease, and evaluating for any...
At the inaugural APP Instititute Inflammatory Bowel Disease, FNP, reviews how to establish a diagnosis of inflammatory bowel disease, including determining their phenotype, assessing the severity of their disease, and evaluating for any...
At the inaugural APP Instititute...
08/14/2024
APP Institute Inflammatory Bowel Disease
Rubin-Kametas
Conference Coverage
APP Institute IBD Opens With “Back to Basics”
08/01/2024
The two-day virtual meeting begins with an overview of the basics of inflammatory bowel disease presented by Marita Kametas, MSN, APN, and David Rubin, MD, from the University of Chicago.
The two-day virtual meeting begins with an overview of the basics of inflammatory bowel disease presented by Marita Kametas, MSN, APN, and David Rubin, MD, from the University of Chicago.
The two-day virtual meeting...
08/01/2024
APP Institute Inflammatory Bowel Disease
Kim Orleck, Kim Kearns
Video
Cochairs Preview First APP Institute Inflammatory Bowel Disease
07/22/2024
Kimberly Orleck and Kim Kearns, APP Institute Inflammatory Bowel Disease cochairs, provide a quick preview of the exciting agenda for the inaugural two-day virtual event.
Kimberly Orleck and Kim Kearns, APP Institute Inflammatory Bowel Disease cochairs, provide a quick preview of the exciting agenda for the inaugural two-day virtual event.
Kimberly Orleck and Kim Kearns,...
07/22/2024
APP Institute Inflammatory Bowel Disease
Kim Kearns
Video
Kimberly Kearns, MS, APRN, on Diagnostics in IBD
07/01/2024
Kimberly Kearns, MS, APN-BC, delves into the noninvasive and invasive diagnostic tools available to APPs working with patients who have or are suspected of having inflammatory bowel disease.
Kimberly Kearns, MS, APN-BC, delves into the noninvasive and invasive diagnostic tools available to APPs working with patients who have or are suspected of having inflammatory bowel disease.
Kimberly Kearns, MS, APN-BC,...
07/01/2024
APP Institute Inflammatory Bowel Disease
Marita Kametas
Rapid Refresh
Severity vs Activity in IBD
06/26/2024
Marita Kametas, MSN, APN, continues her tutorial on IBD with a review of the disease severity and disease activity, including how they differ and how they can be assessed.
Marita Kametas, MSN, APN, continues her tutorial on IBD with a review of the disease severity and disease activity, including how they differ and how they can be assessed.
Marita Kametas, MSN, APN,...
06/26/2024
APP Institute Inflammatory Bowel Disease
Marita Kametas
Rapid Refresh
UC or CD: What's the Difference?
06/26/2024
Marita Kametas, MSN, APN, from the University of Chicago, begins a series on the basics of inflammatory bowel disease, explaining the differences between ulcerative colitis and Crohn's disease.
Marita Kametas, MSN, APN, from the University of Chicago, begins a series on the basics of inflammatory bowel disease, explaining the differences between ulcerative colitis and Crohn's disease.
Marita Kametas, MSN, APN, from...
06/26/2024
APP Institute Inflammatory Bowel Disease
FDA alert
FDA Alert
FDA Approves Risankizumab for Ulcerative Colitis
06/20/2024
The approval makes risankizumab the first IL-23 specific inhibitor approved for both moderate to severe ulcerative colitis and Crohn's disease.
The approval makes risankizumab the first IL-23 specific inhibitor approved for both moderate to severe ulcerative colitis and Crohn's disease.
The approval makes risankizumab...
06/20/2024
Advances in Inflammatory Bowel Disease Network
From Advances in Inflammatory Bowel Disease Network
Emily Block
APP Perspectives
Top 5 Questions From Patients With IBD
03/26/2024
Emily Block, APRN, from Northwestern Medicine, reviews the 5 most frequent questions that patients with inflammatory bowel disease ask of her and other APPs in IBD centers, and what she does to provide the best answers.
Emily Block, APRN, from Northwestern Medicine, reviews the 5 most frequent questions that patients with inflammatory bowel disease ask of her and other APPs in IBD centers, and what she does to provide the best answers.
Emily Block, APRN, from...
03/26/2024
APP Institute Inflammatory Bowel Disease
Marita Kametas
APP Perspectives
Welcome to the APP Institute Inflammatory Bowel Disease!
03/01/2024
Marita Kametas, MSN, APN, introduces the new APP Institute Inflammatory Bowel DIsease and gives a brief overview of the content offerings for advanced practice providers in the IBD field.
Marita Kametas, MSN, APN, introduces the new APP Institute Inflammatory Bowel DIsease and gives a brief overview of the content offerings for advanced practice providers in the IBD field.
Marita Kametas, MSN, APN,...
03/01/2024
APP Institute Inflammatory Bowel Disease
Uma Mahadevan, MD
Clinical Pearls
Caring for the Pregnant Patient With IBD
02/26/2024
Dr Uma Mahadevan discusses the key factors to consider when caring for patients with inflammatory bowel disease who are or who want to become pregnant.
Dr Uma Mahadevan discusses the key factors to consider when caring for patients with inflammatory bowel disease who are or who want to become pregnant.
Dr Uma Mahadevan discusses the...
02/26/2024
APP Institute Inflammatory Bowel Disease

Clinical Pearls

Uma Mahadevan, MD
Clinical Pearls
Caring for the Pregnant Patient With IBD
02/26/2024
Dr Uma Mahadevan discusses the key factors to consider when caring for patients with inflammatory bowel disease who are or who want to become pregnant.
Dr Uma Mahadevan discusses the key factors to consider when caring for patients with inflammatory bowel disease who are or who want to become pregnant.
Dr Uma Mahadevan discusses the...
02/26/2024
APP Institute Inflammatory Bowel Disease
David Rubin
Clinical Pearls
Dose Optimization of Anti-TNF Therapy for IBD
02/26/2024
Dr David Rubin provides a guideline for optimizing adalimumab and infliximab in treating patients with inflammatory bowel disease.
Dr David Rubin provides a guideline for optimizing adalimumab and infliximab in treating patients with inflammatory bowel disease.
Dr David Rubin provides a...
02/26/2024
APP Institute Inflammatory Bowel Disease
Laura Raffals
Clinical Pearls
Top Clinical Pearls for Managing Ulcerative Colitis
01/21/2023
Dr Laura Raffals from Mayo Clinic discusses her top clinical tips for ensuring proper diagnosis, treatment, monitoring, and management of patients with ulcerative colitis.
Dr Laura Raffals from Mayo Clinic discusses her top clinical tips for ensuring proper diagnosis, treatment, monitoring, and management of patients with ulcerative colitis.
Dr Laura Raffals from Mayo...
01/21/2023
APP Institute Inflammatory Bowel Disease

APP Perspectives

Marita Kametas
APP Perspectives
Welcome to the APP Institute Inflammatory Bowel Disease!
03/01/2024
Marita Kametas, MSN, APN, introduces the new APP Institute Inflammatory Bowel DIsease and gives a brief overview of the content offerings for advanced practice providers in the IBD field.
Marita Kametas, MSN, APN, introduces the new APP Institute Inflammatory Bowel DIsease and gives a brief overview of the content offerings for advanced practice providers in the IBD field.
Marita Kametas, MSN, APN,...
03/01/2024
APP Institute Inflammatory Bowel Disease
Kim Orleck
APP Perspectives
Tracking Productivity in IBD Care for APPs
02/26/2024
Kimberly Orleck reviews how much of an APP's work in an IBD practice may not be carefully tracked or compensated for, and how to
Kimberly Orleck reviews how much of an APP's work in an IBD practice may not be carefully tracked or compensated for, and how to
Kimberly Orleck reviews how much...
02/26/2024
APP Institute Inflammatory Bowel Disease
Erin Darguzas
APP Perspectives
The APP-MD Relationship
02/25/2024
Erin Darguzas, APN, from Northwestern Medicine in Chicago reviews how physician training culture and expectations are very different from APP training and onboarding and how this can affect expectations and the way APPs are incorporated into...
Erin Darguzas, APN, from Northwestern Medicine in Chicago reviews how physician training culture and expectations are very different from APP training and onboarding and how this can affect expectations and the way APPs are incorporated into...
Erin Darguzas, APN, from...
02/25/2024
APP Institute Inflammatory Bowel Disease

Rapid Refresh

Kim Kearns
Video
Kimberly Kearns, MS, APRN, on Diagnostics in IBD
07/01/2024
Kimberly Kearns, MS, APN-BC, delves into the noninvasive and invasive diagnostic tools available to APPs working with patients who have or are suspected of having inflammatory bowel disease.
Kimberly Kearns, MS, APN-BC, delves into the noninvasive and invasive diagnostic tools available to APPs working with patients who have or are suspected of having inflammatory bowel disease.
Kimberly Kearns, MS, APN-BC,...
07/01/2024
APP Institute Inflammatory Bowel Disease
Marita Kametas
Rapid Refresh
Severity vs Activity in IBD
06/26/2024
Marita Kametas, MSN, APN, continues her tutorial on IBD with a review of the disease severity and disease activity, including how they differ and how they can be assessed.
Marita Kametas, MSN, APN, continues her tutorial on IBD with a review of the disease severity and disease activity, including how they differ and how they can be assessed.
Marita Kametas, MSN, APN,...
06/26/2024
APP Institute Inflammatory Bowel Disease
Marita Kametas
Rapid Refresh
UC or CD: What's the Difference?
06/26/2024
Marita Kametas, MSN, APN, from the University of Chicago, begins a series on the basics of inflammatory bowel disease, explaining the differences between ulcerative colitis and Crohn's disease.
Marita Kametas, MSN, APN, from the University of Chicago, begins a series on the basics of inflammatory bowel disease, explaining the differences between ulcerative colitis and Crohn's disease.
Marita Kametas, MSN, APN, from...
06/26/2024
APP Institute Inflammatory Bowel Disease

Visit Our Other APP Institutes

APP Institute Inflammatory Bowel Disease

 

The APP Institute is dedicated to educating and informing advanced practice providers on clinical topics and practical issues to support the profession and improve the quality of care for patients with inflammatory bowel disease.

The APP Institute | IBD is designed for Advanced Practice Providers who specialize in Inflammatory Bowel Diseases, to further their education and increase their knowledge to achieve better patient outcomes. Explore cutting-edge research, innovative treatment options, and new therapeutic methods, while remaining focused on the fundamental principles and terminology associated with IBD. Engage year-round with the AIBD Network to access clinical insights, interactive features, research news updates, accredited continuing education programs, and more.

 

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use